Back to Search
Start Over
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial.
- Source :
-
Thrombosis Research . Aug2022, Vol. 216, p125-128. 4p. - Publication Year :
- 2022
-
Abstract
- • Widespread microthrombosis is considered as an etiology for impaired oxygenation in patients with COVID-19 with ARDS. • Systemic thrombolytic versus prophylactic- and therapeutic-dose anticoagulation were compared in present study. • Systematic thrombolytic therapy did not improve oxygenation in critically ill patients with COVID-19. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00493848
- Volume :
- 216
- Database :
- Academic Search Index
- Journal :
- Thrombosis Research
- Publication Type :
- Academic Journal
- Accession number :
- 157993327
- Full Text :
- https://doi.org/10.1016/j.thromres.2021.12.003